273 results on '"Pharmaceutical research -- Methods"'
Search Results
102. New approaches push antibodies ahead
103. Use of LC grows in MS sample prep
104. Fragment-based discovery in spotlight
105. Computational drug discovery: a maturing technology: Dr Stephen Maginn of Chemical Computing Group describes how every drug discovery chemist has become a computational chemist
106. Protein arrays as key discovery tools
107. An 'omics' for the real world
108. Microarray technologies advancing medicine
109. DNA variation on chips, beads and arrays
110. What monitors think of EDC: results of a survey of U.S. monitors: for years, EDC providers have claimed that the technology can increase efficiency and potential cost savings. Survey results indicate that clinical monitors agree
111. Workflow-based software environment for large-scale biological experiments
112. A cell profiling framework for modeling drug responses from HCS imaging
113. Prediction of the structure of a receptor-protein complex using a binary docking method
114. Synthesis of four novel natural product inspired scaffolds for drug discovery
115. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery
116. Findings from State University of New York Yields New Findings on Applied Sciences (Tablet Scoring: Current Practice, Fundamentals, and Knowledge Gaps)
117. Findings from Institute for Molecular Genetics Yields New Data on Biology (Semax As a Universal Drug for Therapy and Research)
118. Study Results from China Pharmaceutical University Update Understanding of Nanoclusters (A Simple and Rapid Fluorescent Approach for Flavonoids Sensor Based On Gold Nanoclusters)
119. New Chromatography Study Findings Have Been Reported by Researchers at Ankara University (The History of the Core-Shell Particles and Applications in Active Pharmaceutical Ingredients Via Liquid Chromatography)
120. Outcome criteria in clinical trials with elderly subjects
121. A business to bank on
122. An intuitive look at the relationship of K(sub.i) and IC(sub.50): a more general use for the Dixon plot
123. Role of Pharmacokinetics and Pharmacodynamics: Does the Dose Matter?
124. Perspective on Animal Models: Chronic Intracellular Infections
125. In Vitro Models, In Vivo Models, and Phaimacokinetics: What Can We Learn from In Vitro Models?
126. Should We Reevaluate Antibiotic Breakpoints?
127. Application of Solid-Phase Microextraction in the Determination of Diazepam Binding to Human Serum Albumin
128. Optimized suspension culture: the rotating-wall vessel
129. Measurement of allergenic potency using the local lymph node assay
130. Enantiomeric Analysis of Pharmaceutical Compounds by Ion/Molecule Reactions
131. Tumor classification using gene expression patterns from DNA microarrays
132. Using peptide aptamers to analyse the proteome
133. Why use more than one electrode at a time?
134. Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
135. Splitting pairs: molecular maneuver aims for better drugs
136. Noncompliance data and clinical outcomes: impact on health care
137. Master method validation protocols
138. Perspective: Who dares, wins
139. Biochemistry: Catalyst clicks drugs together
140. Perspective: Data sharing for discovery
141. Drugmakers target fog of depression: industry and researchers push for reliable ways to assess cognitive deficits associated with mood disorders
142. Capillary electrophoresis and the pharmaceutical industry: a new era
143. An analysis of clearance factor measurements performed by spiking experiments
144. Affymax teams pioneer rapid drug discovery technologies
145. Direct microscopy: an alternative tool for assessment of viability of microfilariae
146. Findings from University of Karachi in the Area of Bioinformatics Described (Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent b-Glucuronidase inhibitors)
147. New drug/device combinations: salvaging dropped compounds
148. The continuing promise of natural products for drug development
149. The development report, part II: a thorough report that captures product development history can save hours of work in tech transfer
150. Statistical testing for outliers: calculating the critical point of the extreme studentized deviation using the beta inverse function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.